Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Wakely PE, Siddiqui MT. Fine-needle aspiration cytopathology of soft tissue myoepithelioma: an analysis of seven cases. J Am Soc Cytopathol. 2022;11(1):31-39.

Young A, Bu W, Jiang W, Ku A, Kapali J, Dhamne S, et al. Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer. Cancer Prev Res (Phila). 2022;15(1):3-10.

Zhao S, Yin C, Zhai Y, Jia Z, Su S, Lu Y, et al. Serum peptidomic screening identified circulating peptide biomarkers predictive for preeclampsia. Front Cardiovasc Med. 2022;9:946433.

McLean-Holden AC, Rooper LM, Lubin DJ, Magliocca KR, Manucha V, Sadow PM, et al. Frankly Invasive Carcinoma Ex-intraductal Carcinoma: Expanding on an Emerging and Perplexing Concept in Salivary Gland Tumor Pathology. Head Neck Pathol. 2022;16(3):657-669.

Velu PD, Cushman-Vokoun A, Ewalt MD, Feilotter H, Gastier-Foster JM, Goswami RS, et al. Alignment of Fellowship Training with Practice Patterns for Molecular Pathologists: A Report of the Association for Molecular Pathology Training and Education Committee. J Mol Diagn. 2022;24(8):825-840.

Leeman-Neill RJ, Soderquist CR, Montanari F, Raciti P, Park D, Radeski D, et al. Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. Haematologica. 2022;107(1):201-210.

Kadri S, Sboner A, Sigaras A, Roy S. Containers in Bioinformatics: Applications, Practical Considerations, and Best Practices in Molecular Pathology. J Mol Diagn. 2022;24(5):442-454.

Gerber N, Vella A, Racine-Brzostek S, Platt SL. Rapid Absolute Neutrophil Count Testing Guides Targeted Antimicrobial Therapy in Febrile Pediatric Oncology Patients. Pediatr Emerg Care. 2022;38(2):e743-e745.

Tsui DC, Aisner D, Nijmeh H, Bao L, Menter A, D Camidge R. Tumor Shrinkage With Combination of Alectinib and Trastuzumab in a Patient With ALK-Rearranged Non-small Cell Lung Cancer Harboring HER2-Amplification as an Acquired Resistance Mechanism to ALK Inhibitor Therapy. Clin Lung Cancer. 2022;23(2):e99-e103.

Kim J, Rustam S, Mosquera JM, Randell SH, Shaykhiev R, Rendeiro AF, et al. Author Correction: Unsupervised discovery of tissue architecture in multiplexed imaging. Nat Methods. 2022;19(12):1662.